Atorvastatin Calcium Tablet
Product Images NDC 68071-3891

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)
Chemical structure of atorvastatin calcium showing the detailed molecular arrangement including aromatic rings, fluorophenyl group, and calcium ion complex with three water molecules.*
FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)
A cumulative incidence line graph comparing Atorvastatin and placebo groups over 3.5 years. The y-axis represents cumulative incidence percentage, and the x-axis represents time in years. The graph shows lower cumulative incidence for Atorvastatin compared to placebo. A hazard ratio (HR) with confidence interval and p-value is also displayed on the chart.*
FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)
A cumulative hazard plot comparing Atorvastatin and placebo over a 5-year follow-up period. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard as a percentage. The plot displays lower cumulative hazard for Atorvastatin compared to placebo, with hazard ratio and p-value indicated.*
FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time (up to 5 years) between two Atorvastatin dosages: 10 mg and 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event.*
FDA Label Image

Pdp (68071 3891 3)

Pdp (68071 3891 3)
Atorvastatin Calcium 20 mg film-coated tablets label from NuCare Pharmaceuticals, Inc. The package contains 30 tablets. Tablets are described as oval-shaped, white to off-white, plain on one side with '114' debossed on the other. Label includes NDC 68071-3891, lot number, expiration date, barcode, and storage instructions to keep at 68-77°F. Warning to keep out of reach of children is present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.